T cells take aim in AML: targeting IDH2.

doi:10.1182/blood.2024023892

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

T cells take aim in AML: targeting IDH2.

Blood - 25 Apr 2024

Subklewe Marion

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Isocitrate Dehydrogenase
Share to Leukemia, Myeloid, Acute
Share to Mutation
Share to T-Lymphocytes

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Open in PubMed

Identifiers

PMID: 38662383
DOI: 10.1182/blood.2024023892

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 10 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

T cells take aim in AML: targeting IDH2.PMID 38662383Read ↗

Targeting IDH: the next big thing in AML.Semantic proximity Read ↗

Hitting the target in IDH2 mutant AML.Semantic proximity Read ↗

Stein EM. IDH2 inhibition in AML. Blood. 2023;141(2):124-125.Semantic proximity Read ↗

Targeting IDH1 and IDH2 Mutations in Acute Myeloid Leukemia.Semantic proximity Read ↗

A pharmacogenomic approach validates AG-221 as an effective and on-target therapy in IDH2 mutant AML.Semantic proximity Read ↗

Molecular pathogenesis of AML: translating insights to the clinic.Semantic proximity Read ↗

Anticancer drugs: IDH2 drives cancer in vivo.Semantic proximity Read ↗

Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL.Semantic proximity Read ↗

Translating recent advances in the pathogenesis of acute myeloid leukemia to the clinic.Semantic proximity Read ↗

The Black Hole: CAR T Cell Therapy in AMLSemantic proximity Read ↗

The Black Hole: CAR T cell Therapy in AMLSemantic proximity Read ↗

Characteristics, clinical outcome, and prognostic significance of IDH mutations in AML.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.